Faslodex 250 mg/5 mL single-dose prefilled syringe Images
Generic Name: fulvestrant
This medication has been identified as Faslodex 250 mg/5 mL single-dose prefilled syringe. It is supplied by AstraZeneca.
Faslodex is used in the treatment of Breast Cancer, Metastatic; Breast Cancer and belongs to the drug classes estrogen receptor antagonists, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Faslodex 250 mg/5 mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Faslodex
- Generic Name
- fulvestrant
- Strength
- 250 mg/5 mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Estrogen receptor antagonists, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-0720
More about Faslodex (fulvestrant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: estrogen receptor antagonists
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.